Cassava Sciences Inc (SAVA) concluded trading on Wednesday at a closing price of $9.57, with 16.04 million shares of worth about $153.46 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -62.82% during that period and on July 17, 2024 the price saw a loss of about -29.27%. Currently the company’s common shares owned by public are about 47.98M shares, out of which, 44.90M shares are available for trading.
Stock saw a price change of -14.25% in past 5 days and over the past one month there was a price change of -51.47%. Year-to-date (YTD), SAVA shares are showing a performance of -57.49% which decreased to -56.34% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $8.79 but also hit the highest price of $32.10 during that period. The average intraday trading volume for Cassava Sciences Inc shares is 1.48 million. The stock is currently trading -34.93% below its 20-day simple moving average (SMA20), while that difference is down -48.63% for SMA50 and it goes to -54.68% lower than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Cassava Sciences Inc (NASDAQ: SAVA) currently have 47.98M outstanding shares and institutions hold larger chunk of about 24.41% of that.
The stock has a current market capitalization of $459.17M and its 3Y-monthly beta is at -0.57. It has posted earnings per share of -$2.16 in the same period. It has Quick Ratio of 1.74 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SAVA, volatility over the week remained 12.55% while standing at 15.41% over the month.
Stock’s fiscal year EPS is expected to rise by 53.74% while it is estimated to increase by 133.54% in next year.
Coverage by B. Riley Securities stated Cassava Sciences Inc (SAVA) stock as a Neutral in their note to investors on November 16, 2022, suggesting a price target of $44 for the stock. On July 15, 2021, Cantor Fitzgerald Downgrade their recommendations, while on July 07, 2021, Maxim Group Reiterated their ratings for the stock with a price target of $190. Stock get a Buy rating from B. Riley Securities on April 27, 2021.
